CPW
ABBV icon

Catalyst Private Wealth’s AbbVie ABBV Stock Holding History

Catalyst Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$214K Buy
+849
New +$183K 0.1% 79
2020
Q4 		– Sell
-485
Closed -$42K – 58
2020
Q3 		$42K Buy
+485
New +$45.7K 0.04% 123

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

Catalyst Private Wealth's ABBV Position: Q2 2026 in Review

Catalyst Private Wealth opened a new position in AbbVie (ABBV) in Q2 2026: 849 shares worth $214K. The stake represents 0.1% of the portfolio and ranks #79 among its holdings. This is a return to the name: Catalyst Private Wealth previously reported a position in ABBV as recently as Q3 2020.

Catalyst Private Wealth first reported a position in ABBV in Q3 2020 and has held it in 2 quarters since. 1,678 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Catalyst Private Wealth held 849 shares of AbbVie worth $214K as of Q2 2026.
  • AbbVie was a new Catalyst Private Wealth position in Q2 2026.
  • AbbVie made up 0.1% of Catalyst Private Wealth's portfolio in Q2 2026, its #79 holding.
  • Catalyst Private Wealth first reported a position in AbbVie in Q3 2020 and has held it in 2 quarters since.
  • 1,678 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Catalyst Private Wealth's 13F filing for Q2 2026, filed 21 Jul 2026.